ALKS vs ALL
Alkermes Plc (ALKS) versus The Allstate Corporation (ALL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
ALL does not have a complete income-statement cache yet.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Not investment advice. Open the ALKS and ALL stock pages for the full models.
Not investment advice.